Manchikanti, Laxmaiah
Sanapati, Jaya
Pampati, Vidyasagar
Kaye, Alan D.
Hirsch, Joshua A.
Article History
First Online: 14 April 2020
Compliance with Ethical Standards
:
: Laxmaiah Manchikanti has provided limited consulting services to Semnur Pharmaceuticals, Incorporated, which is developing nonparticulate steroids. Jaya Sanapati and Vidyasagar Pampati declare no conflict of interest. Alan Kaye is a Section Editor for <i>Current Headache and Pain Reports</i>. He has not been involved in the editorial handling of this manuscript. Dr. Kaye is also a speaker for Merck. Joshua Hirsch is a consultant for Medtronic and on the DMC for Relievent.
: This article does not contain any studies with human or animal subjects performed by any of the authors.